$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical sustained release matrix 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/24
  • A61K-009/26
출원번호 US-0373914 (1995-01-17)
발명자 / 주소
  • Radebaugh Galen W. (Maple Glen PA) Julian Thomas N. (Horsham PA) Glinecke Robert (Glenside PA)
출원인 / 주소
  • McNeil-PPC, Inc. (Milltown NJ 02)
인용정보 피인용 횟수 : 81  인용 특허 : 0

초록

A pharmaceutical sustained release homogeneous tablet or homogeneous tablet layer is formed by making a wet granulation using povidone (PVP) in alcohol as the granulating fluid which is mixed with a pharmaceutical active, ethylcellulose, a wicking agent, e.g. microcrystalline cellulose, an erosion p

대표청구항

A process of preparing a pharmaceutical active sustained release shaped and compressed homogeneous tablet or tablet layer characterized by a long-lasting slow and relatively regular incremental release of the pharmaceutical active upon administration comprising the following steps: A) forming a gran

이 특허를 인용한 특허 (81)

  1. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-clarithromycin antibiotic composition.
  2. Rudnic, Edward M.; Isbiter, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-dicloxacillin antibiotic composition.
  3. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Anti-fungal composition.
  4. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic composition.
  5. Rudnic, Edward M., Antibiotic composition with inhibitor.
  6. Rudnic,Edward M., Antibiotic composition with inhibitor.
  7. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  8. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  9. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  10. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  11. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  12. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  13. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  14. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  15. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  16. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  17. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antiviral product, use and formulation thereof.
  18. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  19. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  20. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Cephalosporin-metronidazole antibiotic composition.
  21. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Ciprofoxacin-metronidazole antibiotic composition.
  22. Flanner, Henry H.; Guttendorf, Robert J.; Clausen, Susan P.; Treacy, Donald; Burnside, Beth A., Compositions and methods for improved efficacy of penicillin-type antibiotics.
  23. Hussain,Javed; Khapra,Pankaj; Gosavi,Arun S., Controlled release compositions for macrolide antimicrobial agents.
  24. Odidi, Isa; Odidi, Amina, Controlled release formulations using intelligent polymers.
  25. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Erythromyacin antibiotic product, use and formulation thereof.
  26. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Fluroquinilone antibiotic product, use and formulation thereof.
  27. Lee Robert ; De Castro Lan, Injectable formulations of nanoparticulate naproxen.
  28. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Levofloxacin antibiotic product, use and formulation thereof.
  29. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Method for providing modified release of ibuprofen.
  30. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Method of forming a tablet.
  31. Kushla, Gregory P.; Lai, Jin-Wang; Polli, Gerald P., Method of making ibuprofen and narcotic analgesic compositions.
  32. Li, Shun-Por; Sowden, Harry S.; Wynn, David; Lee, Der-Yang; Thomas, Martin, Method of manufacturing modified release dosage forms.
  33. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Method of preparing sustained-release preparations of quinolone antibiotics.
  34. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Metronidazole antibiotic product, use and formulation thereof.
  35. Flanner, Henry H.; Tolle-Sander, Sanna; Treacy, Donald; Burnside, Beth A.; Clausen, Susan P., Modified release amoxicillin products.
  36. Sowden, Harry S., Modified release dosage form.
  37. Li, Shun-Por; Sowden, Harry S; Wynn, David; Lee, Der-Yang; Thomas, Martin, Modified release dosage forms.
  38. Sowden, Harry S.; Wynn, David; Li, Shun-Por; Lee, Der-Yang; Thomas, Martin, Modified release dosage forms.
  39. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Modified release ibuprofen dosage form.
  40. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  41. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-neoplastic product, use and formulation thereof.
  42. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-viral product, use and formulation thereof.
  43. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release antifungal product, use and formulation thereof.
  44. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed released antibiotic product, use and formulation thereof.
  45. Rudnic, Edward M; Isbister, James D; Treacy, Jr., Donald J; Wassink, Sandra E, Once a day amoxicillin product comprising immediate and delayed release dosage forms.
  46. Flanner, Henry H.; Guttendorf, Robert; Treacy, Donald; Clausen, Susan P.; Burnside, Beth A., Pharmaceutical compositions and methods for improved bacterial eradication.
  47. Bob E. Sherwood ; John H. Staniforth GB; Edward A. Hunter, Pharmaceutical excipient having improved compressibility.
  48. John N. Staniforth GB; Bob E. Sherwood ; Edward A. Hunter, Pharmaceutical excipient having improved compressibility.
  49. Sherwood Bob E. ; Staniforth John H.,GBX ; Hunter Edward A., Pharmaceutical excipient having improved compressibility.
  50. Sherwood Bob E. ; Staniforth John H.,GBX ; Hunter Edward A., Pharmaceutical excipient having improved compressibility.
  51. Sherwood, Bob E.; Staniforth, John H.; Hunter, Edward A., Pharmaceutical excipient having improved compressibility.
  52. Staniforth, John N.; Hunter, Edward A.; Sherwood, Bob E., Pharmaceutical excipient having improved compressibility.
  53. Staniforth, John N.; Sherwood, Bob E.; Hunter, Edward A., Pharmaceutical excipient having improved compressibility.
  54. Staniforth John N.,GBX ; Sherwood Bob E. ; Hunter Edward A., Pharmaceutical formulations having improved disintegration and/or absorptivity.
  55. Harrison, Nancy; MacDonald, I. David; Takacs-Cox, Aniko; Miller, Robert, Pharmacokinetics of S-adenosylmethionine formulations.
  56. Harrison, Nancy; MacDonald, I. David; Takacs-Cox, Aniko; Miller, Robert, Pharmacokinetics of S-adenosylmethionine formulations.
  57. Harrison, Nancy; MacDonald, I. David; Takacs-Cox, Aniko; Miller, Robert, Pharmacokinetics of S-adenosylmethionine formulations.
  58. Harrison, Nancy; MacDonald, I. David; Takacs-Cox, Aniko; Miller, Robert, Pharmacokinetics of S-adenosylmethionine formulations.
  59. Harrison, Nancy; MacDonald, I. David; Takacs-Cox, Aniko; Miller, Robert, Pharmacokinetics of S-adenosylmethionine formulations.
  60. Vandecruys, Roger Petrus Gerebern; Jans, Eugene Marie Jozef, Pregelatinized starch in a controlled release formulation.
  61. Sharma, Vinay K., Preparation of micron-size pharmaceutical particles by microfluidization.
  62. John N. Staniforth GB; Bob E. Sherwood ; Edward A. Hunter ; Clifford M. Davidson, Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose.
  63. Staniforth, John N.; Sherwood, Bob E.; Hunter, Edward A.; Davidson, Clifford M., Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose.
  64. Cao, Bruce X.; Burnside, Beth A.; Wassink, Sandra E.; Baker, Matt R., Robust pellet.
  65. Jain Rajeev A. ; Wei Linden ; Swanson Jon, Solid dose form of nanoparticulate naproxen.
  66. Ramon A. Frontanes ; Maria S. Bruno ; Hector L. Garcia ; Pahala Simamora ; Maria A. Perez, Stable thyroid hormone preparations and method of making same.
  67. Hanshew, Jr., Dwight D.; Wargo, David John, Storage stable thyroxine active drug formulations and methods for their production.
  68. Hanshew, Jr., Dwight D.; Wargo, David John, Storage stable thyroxine active drug formulations and methods for their production.
  69. Hanshew, Jr.,Dwight D.; Wargo,David John, Storage stable thyroxine active drug formulations and methods for their production.
  70. Hanshew, Jr.,Dwight D.; Wargo,David John, Storage stable thyroxine active drug formulations and methods for their production.
  71. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics.
  72. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Staβ, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics and method for preparation thereof.
  73. Cao, Bruce; Wassink, Sandra E.; Treacy, Jr., Donald J.; Burnside, Beth A.; Rowlings, Colin E.; Bonck, John A., Tablet for pulsed delivery.
  74. Ono, Akihiko; Marunaka, Shigeyuki; Fukuta, Makoto, Tablet preparation without causing a tableting trouble.
  75. Flath, Robert P.; Masselink, John K., Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same.
  76. Abreu, Osvaldo, Tamper resistant dosage form comprising an adsorbent and an adverse agent.
  77. Abreu, Osvaldo, Tamper resistant dosage form comprising an adsorbent and an adverse agent.
  78. Oshlack, Benjamin; Huang, Hua-Pin, Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same.
  79. Oshlack, Benjamin; Huang, Hua-Pin, Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same.
  80. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline antibiotic product, use and formulation thereof.
  81. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline--doxycycline antibiotic composition.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로